๐ŸŒ EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

๐Ÿงช

Trial Match

Clinical trials test new treatments โ€” sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

๐ŸŽฏ Match trials to me

30 recruiting trials

for Sclerosis

VR and Orthoses for Rehabilitation in Multiple Sclerosis NCT07096700NA2 sites๐Ÿ“ Bologna๐Ÿ“ Bologna Azienda Usl di Bologna ยท Tests: VR and walking brace-based gait rehabilitation "Balance, Gait, and Motion Analysis in Multiple Sclerosis" NCT07630311n/a2 sites๐Ÿ“ Ioannina๐Ÿ“ Pรกtrai University of Patras Controlling Amyotrophic Lateral Sclerosis Motor Neuron Excitability Study NCT06649955NA1 site๐Ÿ“ Boston PathMaker Neurosystems Inc. ยท Tests: Multi-site direct current stimulation (DCS) Intermittent Fasting and Mediterranean Diet in Patient With Multiple Sclerosis NCT06546033NA1 site๐Ÿ“ NiฤŸde Nigde Omer Halisdemir University ยท Tests: application of different types of diet Hypercaloric PEG Nutrition in ALS to Sustain Energy Homeostasis NCT06877143NA1 site๐Ÿ“ Ulm University of Ulm ยท Tests: 100% of individual calory requirement, 120% of individual calory requirement MRI-Based Lesion Differentiation in Older Patients With Multiple Sclerosis NCT07444047n/a1 site๐Ÿ“ Oslo Oslo University Hospital Investigation on the Cortical Communication System NCT06207591NA1 site๐Ÿ“ Utrecht UMC Utrecht ยท Tests: ECoG (electrocorticography) sensing Neurodegenerative Diseases Progression Markers (MARKERS-NDD) NCT06596746n/a1 site๐Ÿ“ Cassino Casa di Cura San Raffaele Cassino ยท Tests: Observation High-Intensity, Dynamic-stability Gait Training in People With Multiple Sclerosis NCT05735691NA2 sites๐Ÿ“ Indianapolis๐Ÿ“ Milwaukee Marquette University ยท Tests: High-Intensity Treadmill Training, Treadmill Training with Perturbations, Standard Treadmill Training Light Stimulation to Improve Visual Function After Optic Neuritis in Persons with Multiple Sclerosis NCT06389968NA1 site๐Ÿ“ Munich Technical University of Munich ยท Tests: Light stimulation, Sham light stimulation A Prospective Randomized Non-inferiority Trial Comparing Anti-CD20 Maintenance Versus De-Escalation Strategy In Relapsing-Remitting Multiple Sclerosis NCT07189325Phase 31 site๐Ÿ“ Montpellier University Hospital, Montpellier ยท Tests: Platform therapies (Dimethyl Fumarate, Teriflunomide, Glatiramer Acetate, Beta-interferons), Anti-CD20 therapies (Ocrelโ€ฆ Axatilimab for Sclerotic Chronic Graft-versus-Host Disease NCT07011810Phase 23 sites๐Ÿ“ Tampa๐Ÿ“ Boston๐Ÿ“ Seattle Fred Hutchinson Cancer Center ยท Tests: Axatilimab, Biospecimen Collection, Questionnaire Administration, Skin Biopsy, Skin Measurement Exploring the Efficacy and Safety of Ofatumumab in Patients With Relapsing Multiple Sclerosis (RMS) and Its Impact on Serum Neurofilament Light Chain (sNfL) Levels NCT07353216n/a1 site๐Ÿ“ Guangzhou Third Affiliated Hospital, Sun Yat-Sen University ยท Tests: Ofatumumab Multimodal Imaging Signatures of the Biological Mechanisms Underlying Neurodegeneration in Multiple Sclerosis NCT05633875n/a1 site๐Ÿ“ Paris Assistance Publique - Hรดpitaux de Paris ยท Tests: MRI A Specialized Diet for Multiple Sclerosis NCT07033975NA1 site๐Ÿ“ Diepenbeek Jerome J. A. Hendriks ยท Tests: Flavonoid-enriched Mediterranean Diet Efficacy and Safety of Rapamycin Versus Vigabatrin in the Prevention of Tuberous Sclerosis Complex Symptoms in Infants NCT04987463Phase 2, Phase 32 sites๐Ÿ“ Warsaw๐Ÿ“ Warsaw Katarzyna Kotulska ยท Tests: Vigabatrin, Rapamycin, Placebo, Placebo A Study of Anti-CD19 Chimeric Antigen Receptor T-Cell ( CAR-T) Therapy in Subjects With Non-relapsing and Progressive Forms of Multiple Sclerosis NCT06138132Phase 11 site๐Ÿ“ Palo Alto Stanford University ยท Tests: KYV-101 anti-CD19 CAR-T cell therapy, Standard lymphodepletion regimen A Phase 1/2 Study of PRO-203 in Healthy Volunteers and Participants With Systemic Sclerosis. NCT07641634Phase 1, Phase 213 sites๐Ÿ“ Melbourne๐Ÿ“ Beijing๐Ÿ“ Guangzhou Prolium Bioscience, Inc ยท Tests: PRO-203, Placebo Home Based Functional Balance Intervention for Multiple Sclerosis NCT07355387NA1 site๐Ÿ“ Chicago University of Illinois at Chicago ยท Tests: Multicomponent balance intervention consisting of four components including dual-tasking, functional strength, vestibulโ€ฆ Spinal Cord Associative Plasticity for ALS NCT06172621NA1 site๐Ÿ“ The Bronx VA Office of Research and Development ยท Tests: Spinal Cord Associative Plasticity (SCAP), Upper extremity task-oriented exercise A Study of LTX-002 in Adult Participants With Amyotrophic Lateral Sclerosis NCT07660614Phase 1, Phase 25 sites๐Ÿ“ Lรผbeck๐Ÿ“ Milan๐Ÿ“ Torino Leal Therapeutics, Inc ยท Tests: LTX-002, Placebo (aCSF) An Clinical Study of YTS109 Cell Injection in Subjects With Recurrent/Refractory Autoimmune Disease NCT06379646NA1 site๐Ÿ“ Shanghai China Immunotech (Beijing) Biotechnology Co., Ltd. ยท Tests: YTS109 Classification of Upper and Lower Limb Spasticity Patterns and Their Impact on Quality of Life in Patients With Multiple Sclerosis NCT07466823n/a1 site๐Ÿ“ Istanbul Marmara University ยท Tests: Observational Assessment Nasal Foralumab in Patients With Non-Active Secondary Progressive Multiple Sclerosis NCT06890923Phase 21 site๐Ÿ“ Boston Tiziana Life Sciences LTD ยท Tests: Foralumab TZLS-401 100 ยตg A Registered Cohort Study on Amyotrophic Lateral Sclerosis NCT04008329n/a1 site๐Ÿ“ Fuzhou First Affiliated Hospital of Fujian Medical University A Study Evaluating the Real World Experience of Participants Treated With BRIUMVIยฎ (Ublituximab-xiiy) for Relapsing Multiple Sclerosis (RMS) NCT06433752n/a111 sites๐Ÿ“ Birmingham๐Ÿ“ Cullman๐Ÿ“ Huntsville TG Therapeutics, Inc. ยท Tests: No Intervention Clinical Study to Evaluate the Efficacy and Safety of FB1006 in the Treatment of ALS Patients NCT05923905Phase 41 site๐Ÿ“ Beijing Peking University Third Hospital ยท Tests: FB1006, Placebo CAR-T Cells Therapy for Patients With Autoimmune Diseases NCT07052565NA1 site๐Ÿ“ Hefei Anhui Provincial Hospital ยท Tests: Anti-BCMA and CD19 CART cells will be injected intravenously on a one-time basis Phase IIa Trial of Anti-CD19 CAR T-Cells in Systemic Sclerosis Resistant to Immunosuppressive Therapy NCT07493395Phase 24 sites๐Ÿ“ Lille๐Ÿ“ Montpellier๐Ÿ“ Paris University Hospital, Montpellier ยท Tests: CD19 CAR T Arm Safety, PK and Biodistribution of 18F-OP-801 in Patients With ALS, AD, MS, PD and Healthy Volunteers NCT05395624Phase 1, Phase 23 sites๐Ÿ“ San Francisco๐Ÿ“ Stanford๐Ÿ“ Jacksonville Ashvattha Therapeutics, Inc. ยท Tests: 18F-OP-801
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy